We are excited to announce that Biocytogen will participate in the Milner Therapeutics Symposium 2025! This leading event brings together academic and industry experts to explore the latest advancements in biomedical research and therapeutic innovation. Join us on June 30th in Cambridge to connect with our team, learn our latest materials, and learn how Biocytogen drives progress in antibody discovery and preclinical development.
What is the Milner Therapeutics Symposium 2025?
The Milner Therapeutics Symposium 2025 is a leading annual event that brings together academic and industry experts to share cutting-edge biomedical research and its applications in pharma and biotech. This year’s program features keynote speakers including Noubar Afeyan (Flagship Pioneering) and other top voices from academia and industry.
Event Overview
Date: June 30, 2025 | Time: 12:00 pm - 6:30 pm
Venue: West Road Concert Hall, 11 West Road, Cambridge, Cambridgeshire CB3 9DP, United Kingdom
Event Schedule
The Milner Therapeutics Symposium 2025 is a one-day hybrid event featuring keynote presentations and scientific sessions from leading experts in academia and industry. For more information, please refer to Milner Therapeutics Symposium 2025.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the Milner Therapeutics Symposium 2025!
